When a stock is in consolidation move over a few weeks, it might just be the right time for investors to look into it a bit more closely and that brings us to the subject of the plant protein company Burcon Nutrascience (NASDAQ:BRCN).
In this regard, it should be noted that Corey Hammill, an analyst at Paradigm Capital, has stated that at this point the Burcon stock presents a buying opportunity for investors. He maintained his buy rating on the stock and the 12 month target price of $6 a share.
He went on to state that the second half of 2021 could actually bring in more positive triggers for the Burcon stock and may be the right time for investors to get into the stock. The company is involved in the protein purification and extraction space and is known for its patented brand of proteins. The Burcon stock could be added to the watch list by investors following the recommendation from Hammill.
Market Reaction:
On Thursday, BRCN stock fell by 3.15% to $3.05 with more than 67K shares, compared to its average volume of 75K shares. The stock has moved within a range of $2.9600 – 3.1300 after opening the trade at $3.10. Over the past 52-week, the stock has been trading within a range of $1.0600 – 4.6600.
Moving Averages
| +/- EMA(20) | 3.29 (-7.29%) |
| +/- SMA(50) | 3.63 (-15.98%) |
| +/- SMA(200) | 2.89 (+5.54%) |
Key Performances
| 5-DAY PERF. | +0.66% |
| 1-MONTH PERF. | -11.87% |
| 3-MONTH PERF. | -15.98% |
| 6-MONTH PERF. | +27.08% |
| YTD PERF. | +12.96% |
| 1-YEAR PERF. | +182.40% |
 Stock Moves in a Range: A Breakout Coming?){kind=link}